FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2966243336> ?p ?o ?g. }

• W2966243336 endingPage "163" @default.
• W2966243336 startingPage "153" @default.
• W2966243336 abstract "Neointima hyperplasia is the pathological basis of atherosclerosis and restenosis which have been associated with diabetes mellitus (DM). It is controversial for linagliptin and metformin to protect against vascular neointimal hyperplasia caused by DM. Given the combined therapy of linagliptin and metformin in clinical practice, we investigated whether the combination therapy inhibited neointimal hyperplasia in the carotid artery in diabetic rats.Neointima hyperplasia in the carotid artery was induced by balloon-injury in the rats fed with high fat diet (HFD) combined with low dose streptozotocin (STZ) administration. In vitro, vascular smooth muscle cells (VSMCs) were incubated with high glucose (HG, 30 mM) and the proliferation, migration, apoptosis and collagen deposition were analyzed in VSMCs. We found that the combined therapy, not the monotherapy of linagliptin and metformin significantly inhibited the neointima hyperplasia and improved the endothelium-independent contraction in the balloon-injured cardia artery of diabetic rats, which was associated with the inhibition of superoxide (O2-.) production in the cardia artery. In vitro, HG-induced VSMC remodeling was shown as the remarkable upregulation of PCNA, collagan1, MMP-9, Bcl-2 and migration rate as well as the decreased apoptosis rate. Such abnormal changes were dramatically reversed by the combined use of linagliptin and metformin. Moreover, the AMP-activated protein kinase (AMPK)/Nox4 signal pathway was found to mediate VSMC remodeling responding to HG. Linagliptin and metformin were synergistical to target AMPK/Nox4 signal pathway in VSMCs incubated with HG and in the cardia artery of diabetic rats, which was superior to the monotherapy.We demonstrated that the potential protection of the combined use of linagliptin and metformin on VSMC remodeling through AMPK/Nox4 signal pathway, resulting in the improvement of neointima hyperplasia in diabetic rats. This study provided new therapeutic strategies for vascular stenosis associated with diabetes." @default.
• W2966243336 created "2019-08-13" @default.
• W2966243336 creator A5017188043 @default.
• W2966243336 creator A5022420704 @default.
• W2966243336 creator A5080217808 @default.
• W2966243336 creator A5089038082 @default.
• W2966243336 date "2019-11-01" @default.
• W2966243336 modified "2023-10-17" @default.
• W2966243336 title "Inhibition of neointima hyperplasia by the combined therapy of linagliptin and metformin via AMPK/Nox4 signaling in diabetic rats" @default.
• W2966243336 cites W105508996 @default.
• W2966243336 cites W1483874092 @default.
• W2966243336 cites W1503466466 @default.
• W2966243336 cites W1549622883 @default.
• W2966243336 cites W1588051322 @default.
• W2966243336 cites W1999381401 @default.
• W2966243336 cites W2014609417 @default.
• W2966243336 cites W2028011534 @default.
• W2966243336 cites W2033810451 @default.
• W2966243336 cites W2045116801 @default.
• W2966243336 cites W2049368067 @default.
• W2966243336 cites W2080612545 @default.
• W2966243336 cites W2081276121 @default.
• W2966243336 cites W2090372317 @default.
• W2966243336 cites W2091617543 @default.
• W2966243336 cites W2101072007 @default.
• W2966243336 cites W2108722331 @default.
• W2966243336 cites W2113506865 @default.
• W2966243336 cites W2118812428 @default.
• W2966243336 cites W2120582497 @default.
• W2966243336 cites W2122476748 @default.
• W2966243336 cites W2128562466 @default.
• W2966243336 cites W2132828650 @default.
• W2966243336 cites W2140307562 @default.
• W2966243336 cites W2146257601 @default.
• W2966243336 cites W2153393998 @default.
• W2966243336 cites W2166259521 @default.
• W2966243336 cites W2172193326 @default.
• W2966243336 cites W2177504159 @default.
• W2966243336 cites W2208910479 @default.
• W2966243336 cites W2274924551 @default.
• W2966243336 cites W2311780899 @default.
• W2966243336 cites W2478055166 @default.
• W2966243336 cites W2479269302 @default.
• W2966243336 cites W2523321497 @default.
• W2966243336 cites W2528806415 @default.
• W2966243336 cites W2531934030 @default.
• W2966243336 cites W2550058261 @default.
• W2966243336 cites W2552060428 @default.
• W2966243336 cites W2560089197 @default.
• W2966243336 cites W2592371738 @default.
• W2966243336 cites W2611480341 @default.
• W2966243336 cites W2760658785 @default.
• W2966243336 cites W2781957752 @default.
• W2966243336 cites W2782491382 @default.
• W2966243336 cites W2802336842 @default.
• W2966243336 cites W2897398904 @default.
• W2966243336 doi "https://doi.org/10.1016/j.freeradbiomed.2019.07.030" @default.
• W2966243336 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31369842" @default.
• W2966243336 hasPublicationYear "2019" @default.
• W2966243336 type Work @default.
• W2966243336 sameAs 2966243336 @default.
• W2966243336 citedByCount "18" @default.
• W2966243336 countsByYear W29662433362020 @default.
• W2966243336 countsByYear W29662433362021 @default.
• W2966243336 countsByYear W29662433362022 @default.
• W2966243336 countsByYear W29662433362023 @default.
• W2966243336 crossrefType "journal-article" @default.
• W2966243336 hasAuthorship W2966243336A5017188043 @default.
• W2966243336 hasAuthorship W2966243336A5022420704 @default.
• W2966243336 hasAuthorship W2966243336A5080217808 @default.
• W2966243336 hasAuthorship W2966243336A5089038082 @default.
• W2966243336 hasConcept C126322002 @default.
• W2966243336 hasConcept C134018914 @default.
• W2966243336 hasConcept C184235292 @default.
• W2966243336 hasConcept C2777180221 @default.
• W2966243336 hasConcept C2777339539 @default.
• W2966243336 hasConcept C2778095995 @default.
• W2966243336 hasConcept C2778283817 @default.
• W2966243336 hasConcept C2778583881 @default.
• W2966243336 hasConcept C2779395532 @default.
• W2966243336 hasConcept C2780031085 @default.
• W2966243336 hasConcept C2780124434 @default.
• W2966243336 hasConcept C2780323712 @default.
• W2966243336 hasConcept C2992686903 @default.
• W2966243336 hasConcept C555293320 @default.
• W2966243336 hasConcept C71924100 @default.
• W2966243336 hasConcept C86803240 @default.
• W2966243336 hasConcept C95444343 @default.
• W2966243336 hasConcept C97029542 @default.
• W2966243336 hasConcept C98274493 @default.
• W2966243336 hasConceptScore W2966243336C126322002 @default.
• W2966243336 hasConceptScore W2966243336C134018914 @default.
• W2966243336 hasConceptScore W2966243336C184235292 @default.
• W2966243336 hasConceptScore W2966243336C2777180221 @default.
• W2966243336 hasConceptScore W2966243336C2777339539 @default.
• W2966243336 hasConceptScore W2966243336C2778095995 @default.
• W2966243336 hasConceptScore W2966243336C2778283817 @default.
• W2966243336 hasConceptScore W2966243336C2778583881 @default.

• next